Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor

Affiliations

• ¹ Department of Onco-Rheumatology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
• ² Department of Infectious Diseases, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
• ³ Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
• ⁴ Department of Dermatology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
• ⁵ Department of Emergency Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
• ⁶ Department of Onco-Cardiology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
• ⁷ Division of Early Clinical Development for Cancer, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
• ⁸ Division of Cancer Immunotherapy Development, Advanced Medical Development Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.